Report Colombia - Medicaments of Penicillins, Streptomycins or Derivatives Thereof - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Mar 1, 2026

Colombia - Medicaments of Penicillins, Streptomycins or Derivatives Thereof - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Colombia: Market for Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof 2026

Market Size for Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof in Colombia

The Colombian penicillins or streptomycins medicaments market reached $X in 2025, flattening at the previous year. The market value increased at an average annual rate of X% over the period from 2012 to 2025; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. Penicillins or streptomycins medicaments consumption peaked at $X in 2022; however, from 2023 to 2025, consumption stood at a somewhat lower figure.

Production of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof in Colombia

In value terms, penicillins or streptomycins medicaments production reached $X in 2025 estimated in export price. Over the period under review, production recorded a relatively flat trend pattern. The most prominent rate of growth was recorded in 2014 with an increase of X% against the previous year. Penicillins or streptomycins medicaments production peaked at $X in 2015; however, from 2016 to 2025, production stood at a somewhat lower figure.

Exports of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof

Exports from Colombia

For the third consecutive year, Colombia recorded growth in overseas shipments of medicaments of penicillins, streptomycins or derivatives thereof, which increased by X% to X tons in 2025. Over the period under review, exports, however, showed a mild decline. The pace of growth appeared the most rapid in 2020 when exports increased by X%. The exports peaked at X tons in 2016; however, from 2017 to 2025, the exports stood at a somewhat lower figure.

In value terms, penicillins or streptomycins medicaments exports expanded slightly to $X in 2025. In general, exports, however, continue to indicate a noticeable decline. The growth pace was the most rapid in 2020 with an increase of X% against the previous year. The exports peaked at $X in 2014; however, from 2015 to 2025, the exports stood at a somewhat lower figure.

Exports by Country

Chile (X tons), Peru (X tons) and Ecuador (X tons) were the main destinations of penicillins or streptomycins medicaments exports from Colombia, with a combined X% share of total exports. Mexico, Honduras, Guatemala, Bolivia, Panama and Venezuela lagged somewhat behind, together comprising a further X%.

From 2012 to 2025, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Mexico (with a CAGR of X%), while the other leaders experienced more modest paces of growth.

In value terms, Ecuador ($X), Peru ($X) and Chile ($X) were the largest markets for penicillins or streptomycins medicaments exported from Colombia worldwide, with a combined X% share of total exports. Mexico, Guatemala, Honduras, Panama, Venezuela and Bolivia lagged somewhat behind, together accounting for a further X%.

Mexico, with a CAGR of X%, saw the highest rates of growth with regard to the value of exports, in terms of the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2025, the average penicillins or streptomycins medicaments export price amounted to $X per ton, dropping by X% against the previous year. In general, the export price continues to indicate a slight decline. The most prominent rate of growth was recorded in 2021 an increase of X% against the previous year. Over the period under review, the average export prices attained the maximum at $X per ton in 2022; however, from 2023 to 2025, the export prices stood at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Venezuela ($X per ton), while the average price for exports to Chile ($X per ton) was amongst the lowest.

From 2012 to 2025, the most notable rate of growth in terms of prices was recorded for supplies to Bolivia (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof

Imports into Colombia

In 2025, supplies from abroad of medicaments of penicillins, streptomycins or derivatives thereof increased by X% to X tons for the first time since 2021, thus ending a two-year declining trend. Over the period under review, total imports indicated noticeable growth from 2012 to 2025: its volume increased at an average annual rate of X% over the last twelve years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2021 with an increase of X% against the previous year. Over the period under review, imports reached the peak figure in 2025 and are likely to continue growth in the near future.

In value terms, penicillins or streptomycins medicaments imports rose sharply to $X in 2025. Overall, imports, however, continue to indicate a pronounced slump. The most prominent rate of growth was recorded in 2019 when imports increased by X% against the previous year. Imports peaked at $X in 2013; however, from 2014 to 2025, imports stood at a somewhat lower figure.

Imports by Country

In 2025, China (X tons) constituted the largest penicillins or streptomycins medicaments supplier to Colombia, accounting for a X% share of total imports. Moreover, penicillins or streptomycins medicaments imports from China exceeded the figures recorded by the second-largest supplier, Italy (X tons), threefold. The third position in this ranking was taken by Mexico (X tons), with an X% share.

From 2012 to 2025, the average annual rate of growth in terms of volume from China totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: Italy (X% per year) and Mexico (X% per year).

In value terms, Italy ($X), China ($X) and France ($X) appeared to be the largest penicillins or streptomycins medicaments suppliers to Colombia, with a combined X% share of total imports.

In terms of the main suppliers, China, with a CAGR of X%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average penicillins or streptomycins medicaments import price stood at $X per ton in 2025, surging by X% against the previous year. Over the period under review, the import price, however, continues to indicate a drastic downturn. The pace of growth appeared the most rapid in 2017 an increase of X% against the previous year. Over the period under review, average import prices reached the maximum at $X per ton in 2012; however, from 2013 to 2025, import prices stood at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was France ($X per ton), while the price for Mexico ($X per ton) was amongst the lowest.

From 2012 to 2025, the most notable rate of growth in terms of prices was attained by France (X%), while the prices for the other major suppliers experienced mixed trend patterns.

Frequently Asked Questions (FAQ) :

The countries with the highest volumes of consumption in 2024 were China, Turkey and the United States, with a combined 37% share of global consumption.
The countries with the highest volumes of production in 2024 were China, India and Turkey, with a combined 47% share of global production.
In value terms, the largest penicillins or streptomycins medicaments suppliers to Colombia were Italy, China and France, together comprising 51% of total imports.
In value terms, Ecuador, Peru and Chile appeared to be the largest markets for penicillins or streptomycins medicaments exported from Colombia worldwide, with a combined 66% share of total exports. Mexico, Guatemala, Honduras, Panama, Venezuela and Bolivia lagged somewhat behind, together comprising a further 28%.
The average penicillins or streptomycins medicaments export price stood at $21,635 per ton in 2024, falling by -3% against the previous year. Overall, the export price continues to indicate a mild downturn. The most prominent rate of growth was recorded in 2021 when the average export price increased by 25%. The export price peaked at $29,857 per ton in 2022; however, from 2023 to 2024, the export prices stood at a somewhat lower figure.
In 2024, the average penicillins or streptomycins medicaments import price amounted to $38,545 per ton, increasing by 4.8% against the previous year. Overall, the import price, however, continues to indicate a abrupt decline. The growth pace was the most rapid in 2017 when the average import price increased by 22% against the previous year. Over the period under review, average import prices attained the maximum at $90,291 per ton in 2012; however, from 2013 to 2024, import prices stood at a somewhat lower figure.

This report provides a comprehensive view of the penicillins or streptomycins medicaments industry in Colombia, tracking demand, supply, and trade flows across the national value chain. It explains how demand across key channels and end-use segments shapes consumption patterns, while also mapping the role of input availability, production efficiency, and regulatory standards on supply.

Beyond headline metrics, the study benchmarks prices, margins, and trade routes so you can see where value is created and how it moves between domestic suppliers and international partners. The analysis is designed to support strategic planning, market entry, portfolio prioritization, and risk management in the penicillins or streptomycins medicaments landscape in Colombia.

Quick navigation

Key findings

  • Domestic demand is shaped by both household and industrial usage, with trade flows linking local supply to imports and exports.
  • Pricing dynamics reflect unit values, freight costs, exchange rates, and regulatory shifts that affect sourcing decisions.
  • Supply depends on input availability and production efficiency, creating a distinct national cost curve.
  • Market concentration varies by segment, creating different competitive landscapes and entry barriers.
  • The 2035 outlook highlights where capacity investment and demand growth are most aligned within the country.

Report scope

The report combines market sizing with trade intelligence and price analytics for Colombia. It covers both historical performance and the forward outlook to 2035, allowing you to compare cycles, structural shifts, and policy impacts.

  • Market size and growth in value and volume terms
  • Consumption structure by end-use segments
  • Production capacity, output, and cost dynamics
  • Trade flows, exporters, importers, and balances
  • Price benchmarks, unit values, and margin signals
  • Competitive context and market entry conditions

Product coverage

  • Prodcom 21201160 - Medicaments of penicillins, streptomycins or derivatives thereof, in doses or p.r.s.

Country coverage

  • Colombia

Country profile and benchmarks

This report provides a consistent view of market size, trade balance, prices, and per-capita indicators for Colombia. The profile highlights demand structure and trade position, enabling benchmarking against regional and global peers.

Methodology

The analysis is built on a multi-source framework that combines official statistics, trade records, company disclosures, and expert validation. Data are standardized, reconciled, and cross-checked to ensure consistency across time series.

  • International trade data (exports, imports, and mirror statistics)
  • National production and consumption statistics
  • Company-level information from financial filings and public releases
  • Price series and unit value benchmarks
  • Analyst review, outlier checks, and time-series validation

All data are normalized to a common product definition and mapped to a consistent set of codes. This ensures that comparisons across time are aligned and actionable.

Forecasts to 2035

The forecast horizon extends to 2035 and is based on a structured model that links penicillins or streptomycins medicaments demand and supply to macroeconomic indicators, trade patterns, and sector-specific drivers. The model captures both cyclical and structural factors and reflects known policy and technology shifts in Colombia.

  • Historical baseline: 2012-2025
  • Forecast horizon: 2026-2035
  • Scenario-based sensitivity to income growth, substitution, and regulation
  • Capacity and investment outlook for major producing companies

Each projection is built from national historical patterns and the broader regional context, allowing the report to show where growth is concentrated and where risks are elevated.

Price analysis and trade dynamics

Prices are analyzed in detail, including export and import unit values, regional spreads, and changes in trade costs. The report highlights how seasonality, freight rates, exchange rates, and supply disruptions influence pricing and margins.

  • Price benchmarks by country and sub-region
  • Export and import unit value trends
  • Seasonality and calendar effects in trade flows
  • Price outlook to 2035 under baseline assumptions

Profiles of market participants

Key producers, exporters, and distributors are profiled with a focus on their operational scale, geographic footprint, product mix, and market positioning. This helps identify competitive pressure points, partnership opportunities, and routes to differentiation.

  • Business focus and production capabilities
  • Geographic reach and distribution networks
  • Cost structure and pricing strategy indicators
  • Compliance, certification, and sustainability context

How to use this report

  • Quantify domestic demand and identify the most attractive segments
  • Evaluate export opportunities and prioritize target destinations
  • Track price dynamics and protect margins
  • Benchmark performance against leading competitors
  • Build evidence-based forecasts for investment decisions

This report is designed for manufacturers, distributors, importers, wholesalers, investors, and advisors who need a clear, data-driven picture of penicillins or streptomycins medicaments dynamics in Colombia.

FAQ

What is included in the penicillins or streptomycins medicaments market in Colombia?

The market size aggregates consumption and trade data, presented in both value and volume terms.

How are the forecasts to 2035 built?

The projections combine historical trends with macroeconomic indicators, trade dynamics, and sector-specific drivers.

Does the report cover prices and margins?

Yes, it includes export and import unit values, regional spreads, and a pricing outlook to 2035.

Which benchmarks are included?

The report benchmarks market size, trade balance, prices, and per-capita indicators for Colombia.

Can this report support market entry decisions?

Yes, it highlights demand hotspots, trade routes, pricing trends, and competitive context.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND THE AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDSThis Chapter is Available Only for the Professional EditionPRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and its Prospects

    1. MARKET SIZE: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
    2. MARKET STRUCTURE: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
    3. TRADE BALANCE: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
    4. PER CAPITA CONSUMPTION: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
    5. MARKET FORECAST TO 2035
  4. 4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION

    Finding New Products to Diversify Your Business

    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCTS
    4. MOST TRADED PRODUCTS
    5. MOST PROFITABLE PRODUCTS FOR EXPORTS
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Export

    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
    2. IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2025)
    3. IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2025)
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
    2. EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2025)
    3. EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2025)
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

  11. LIST OF TABLES

    1. Key Findings In 2025
    2. Market Volume, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    3. Market Value: Historical Data (2012–2025) and Forecast (2026–2035)
    4. Per Capita Consumption: Historical Data (2012–2025) and Forecast (2026–2035)
    5. Imports, In Physical Terms, By Country, 2012–2025
    6. Imports, In Value Terms, By Country, 2012–2025
    7. Import Prices, By Country, 2012–2025
    8. Exports, In Physical Terms, By Country, 2012–2025
    9. Exports, In Value Terms, By Country, 2012–2025
    10. Export Prices, By Country, 2012–2025
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    2. Market Value: Historical Data (2012–2025) and Forecast (2026–2035)
    3. Market Structure – Domestic Supply vs. Imports, in Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    4. Market Structure – Domestic Supply vs. Imports, in Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    5. Trade Balance, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    6. Trade Balance, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    7. Per Capita Consumption: Historical Data (2012–2025) and Forecast (2026–2035)
    8. Market Volume Forecast to 2035
    9. Market Value Forecast to 2035
    10. Market Size and Growth, By Product
    11. Average Per Capita Consumption, By Product
    12. Exports and Growth, By Product
    13. Export Prices and Growth, By Product
    14. Production Volume and Growth
    15. Exports and Growth
    16. Export Prices and Growth
    17. Market Size and Growth
    18. Per Capita Consumption
    19. Imports and Growth
    20. Import Prices
    21. Production, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    22. Production, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    23. Imports, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    24. Imports, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    25. Imports, In Physical Terms, By Country, 2025
    26. Imports, In Physical Terms, By Country, 2012–2025
    27. Imports, In Value Terms, By Country, 2012–2025
    28. Import Prices, By Country, 2012–2025
    29. Exports, In Physical Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    30. Exports, In Value Terms: Historical Data (2012–2025) and Forecast (2026–2035)
    31. Exports, In Physical Terms, By Country, 2025
    32. Exports, In Physical Terms, By Country, 2012–2025
    33. Exports, In Value Terms, By Country, 2012–2025
    34. Export Prices, By Country, 2012–2025
BioMarin Q4 2025 Revenue Beats Estimates but 2026 Guidance Concerns Investors
Mar 20, 2026

BioMarin Q4 2025 Revenue Beats Estimates but 2026 Guidance Concerns Investors

BioMarin's Q4 2025 revenue beat analyst forecasts, but weak full-year 2026 EPS guidance led to a stock decline, contrasting with sector stability.

Gilead Sciences Stock Outperforms Market Despite Business Quality Concerns
Mar 18, 2026

Gilead Sciences Stock Outperforms Market Despite Business Quality Concerns

Gilead Sciences stock has significantly outperformed the market since March 2021, but an analysis reveals underlying business concerns including slow sales growth and declining financial metrics, suggesting potential better investment opportunities.

Gossamer Bio Reports Q4 2025 Financial Results
Mar 17, 2026

Gossamer Bio Reports Q4 2025 Financial Results

Gossamer Bio's Q4 2025 financial report shows a $47.2M loss but revenue of $13.8M beat analyst predictions, with full-year 2025 revenue at $48.5M.

Kyntra Bio Executives Detail 2025 Progress and Forward-Looking Strategy
Mar 16, 2026

Kyntra Bio Executives Detail 2025 Progress and Forward-Looking Strategy

Kyntra Bio executives detail 2025 progress on key cancer drug candidates and future strategy in a recent conference call, outlining clinical developments and forward-looking business statements.

Assertio Holdings Reviews 2025 Financial Results and Announces Strategic Pivot
Mar 16, 2026

Assertio Holdings Reviews 2025 Financial Results and Announces Strategic Pivot

Assertio Holdings reports on its 2025 financial performance, completes Rolvedon integration, and outlines a new strategy focusing on its core asset while moving away from its previous acquisition-based growth model.

Analysts Identify Divergent Paths for S&P 500 Healthcare and Consumer Stocks
Mar 13, 2026

Analysts Identify Divergent Paths for S&P 500 Healthcare and Consumer Stocks

A recent analysis reveals divergent prospects for S&P 500 companies, with healthcare firms IQVIA and Bristol-Myers Squibb facing specific headwinds, while consumer giant Coca-Cola is highlighted for attention.

G2 reviews
Teams rate IndexBox on G2

Verified reviewers highlight faster qualification, clearer collaboration, and stronger bid readiness.

G2

High Performer

Regional Grid

G2

High Performer Small-Business

Grid Report

G2

Leader Small-Business

Grid Report

G2

High Performer Mid-Market

Grid Report

G2

Leader

Grid Report

G2

Users Love Us

Milestone badge

Cristian Spataru

Cristian Spataru

Commercial Manager · XTRATECRO

5/5

Great for Market Insights and Analysis

“IndexBox is a solid source for trade and industrial market data — what I like best about it is how it aggregates official statistics.”

Review collected and hosted on G2.com.

Juan Pablo Cabrera

Juan Pablo Cabrera

Gerente de Innovación · Cartocor

5/5

Extremely gratifying

“Access very specific and broad information of any type of market.”

Review collected and hosted on G2.com.

Dilan Salam

Dilan Salam

GMP; ISO Compliance Supervisor · PiONEER Co. for Pharmaceutical Industries

5/5

Powerful data at a fair price

“I have got a lot of benefit from IndexBox, too many data available, and easy to use software at a very good price.”

Review collected and hosted on G2.com.

Counselor Hasan AlKhoori

Counselor Hasan AlKhoori

Founder and CEO · Independent

5/5

All the data required

“All the data required for building your full analytics infrastructure.”

Review collected and hosted on G2.com.

Ashenafi Behailu

Ashenafi Behailu

General Manager · Ashenafi Behailu General Contractor

5/5

Detailed, well-organized data

“The data organization and level of detail which it is presented in is very helpful.”

Review collected and hosted on G2.com.

Iman Aref

Iman Aref

Senior Export Manager · Padideh Shimi Gharn

5/5

Up to date and precise info

“Up to date and precise info, for fulfilling the validity and reliability of the given research.”

Review collected and hosted on G2.com.

Top 30 market participants headquartered in Colombia
Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof · Colombia scope

Companies list is being prepared. Please check back soon.

Dashboard for Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof (Colombia)
Demo data

Charts mirror the report figures on the platform. Values are synthetic for demo use.

Market Volume
Demo
Market Volume, in Physical Terms: Historical Data (2013-2025) and Forecast (2026-2036)
Market Value
Demo
Market Value: Historical Data (2013-2025) and Forecast (2026-2036)
Consumption by Country
Demo
Consumption, by Country, 2025
Top consuming countries Share, %
Market Volume Forecast
Demo
Market Volume Forecast to 2036
Market Value Forecast
Demo
Market Value Forecast to 2036
Market Size and Growth
Demo
Market Size and Growth, by Product
Segment Growth, %
Per Capita Consumption
Demo
Per Capita Consumption, by Product
Segment Kg per capita
Per Capita Consumption Trend
Demo
Per Capita Consumption, 2013-2025
Production Volume
Demo
Production, in Physical Terms, 2013-2025
Production Value
Demo
Production Value, 2013-2025
Production by Country
Demo
Production, by Country, 2025
Top producing countries Share, %
Export Price
Demo
Export Price, 2013-2025
Import Price
Demo
Import Price, 2013-2025
Export Price by Country
Demo
Export Price, by Country, 2025
Top export price USD per ton
Import Price by Country
Demo
Import Price, by Country, 2025
Top import price USD per ton
Price Spread
Demo
Export-Import Price Spread, 2013-2025
Average Price
Demo
Average Export Price, 2013-2025
Import Volume
Demo
Import Volume, 2013-2025
Import Value
Demo
Import Value, 2013-2025
Imports by Country
Demo
Imports, by Country, 2025
Top importing countries Share, %
Import Price by Country
Demo
Import Price, by Country, 2025
Top import price USD per ton
Export Volume
Demo
Export Volume, 2013-2025
Export Value
Demo
Export Value, 2013-2025
Exports by Country
Demo
Exports, by Country, 2025
Top exporting countries Share, %
Export Price by Country
Demo
Export Price, by Country, 2025
Top export price USD per ton
Export Growth by Product
Demo
Export Growth, by Product, 2025
Segment Growth, %
Export Price Growth by Product
Demo
Export Price Growth, by Product, 2025
Segment Growth, %
Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof - Colombia - Supplying Countries
Leader in Production
India
Within 50 Countries
Leader in Exports
Ecuador
Within TOP 50 Producing Countries
Leader in Prices
Malawi
Within TOP 50 Exporting Countries
Colombia - Top Producing Countries
Demo
Production Volume vs CAGR of Production Volume
Colombia - Top Exporting Countries
Demo
Export Volume vs CAGR of Exports
Colombia - Low-cost Exporting Countries
Demo
Export Price vs CAGR of Export Prices
Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof - Colombia - Overseas Markets
Largest Importer
United States
Within TOP 50 Importing Countries
Fastest Import Growth
Vietnam
CAGR 2017-2025
Highest Import Price
Japan
USD per ton, 2025
Largest Market Value
Germany
2025
Colombia - Top Importing Countries
Demo
Import Volume vs CAGR of Imports
Colombia - Largest Consumption Markets
Demo
Consumption Volume vs CAGR of Consumption
Colombia - Fastest Import Growth
Demo
Import Growth Leaders, 2025
Colombia - Highest Import Prices
Demo
Import Prices Leaders, 2025
Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof - Colombia - Products for Diversification
Top Diversification Option
Segment A
High synergy with core demand
Fastest Growth
Segment B
CAGR 2017-2025
Highest Margin
Segment C
Premium pricing tier
Lowest Volatility
Segment D
Stable demand trend
Products with the Highest Export Growth
Demo
Export Growth by Product, 2025
Products with Rising Prices
Demo
Price Growth by Product, 2025
Products with High Import Dependence
Demo
Import Dependence Index, 2025
Diversification Shortlist
Demo
Product Rationale
Macroeconomic indicators influencing the Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof market (Colombia)
Live data

Real macro, logistics, and energy indicators are pulled from the IndexBox platform and rendered on demand.

Loading indicators...
No chart data available for macro indicators.
No chart data available for logistics indicators.
No chart data available for energy and commodity indicators.

Recommended reports

Featured reports in Pharmaceutical Products

Market Intelligence

Free Data: Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof - Colombia

Instant access. No credit card needed.